| Authors: |
Robinson HR; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA. Electronic address: hannah.r.robinson@cuanschutz.edu., Lakritz S; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA., Pavlick DC; Foundation Medicine Inc., Cambridge, USA., Davis SL; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA., Lieu CH; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA., Eule CJ; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA., Graham LS; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA., Spiess PE; Moffitt Cancer Center, Tampa, USA., Li R; Moffitt Cancer Center, Tampa, USA., Kamat AM; MD Anderson Cancer Center, Houston, USA., Grivas P; Fred Hutch Cancer Center & University of Washington, Seattle, USA., Jacob JM; State University of New York Upstate Medical University, Syracuse, USA., Bratslavsky G; State University of New York Upstate Medical University, Syracuse, USA., Basnet A; State University of New York Upstate Medical University, Syracuse, USA., Wong KA; Foundation Medicine Inc., Cambridge, USA., Lin DI; Foundation Medicine Inc., Cambridge, USA., Necchi A; San Raffaele Hospital and Scientific Institute, Milan, Italy., Ross JS; Foundation Medicine Inc., Cambridge, USA; State University of New York Upstate Medical University, Syracuse, USA., Lam ET; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, USA. |
